HUTCHMED (China) Limited ADR (H7T1)
FSX
Closed
Oct 9, 2026
Day's Range
11.9052 wk Range
8.45Overview - H7T1 - HUTCHMED (China) Limited ADR
Key Statistics
Valuation
Enterprise Value
717.61M
P/E (Trailing)
‪133.33‬
Price / Sales (TTM)
‪3.79‬
Price / Book
‪1.89‬
EV / EBITDA
‪-39.87‬
Profitability
Gross Margin
‪23.08%‬
Profit Margin
‪3.25%‬
Operating Margin
‪0.31%‬
Return on Assets
‪-1.23%‬
Return on Equity
‪1.46%‬
Ownership
Shares Outstanding
859.74M
Float
104.56M
Held by Insiders
‪0.0089%‬
Held by Institutions
‪2.60%‬
Price stats
Beta
‪0.44‬
50-Day Avg
‪10.62‬
200-Day Avg
‪11.08‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - H7T1 - HUTCHMED (China) Limited ADR
Peers - H7T1 - HUTCHMED (China) Limited ADR
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- H7T1FSXHutchmed (China) Limited American Depositary Shares2.08BMarket Cap-7.50%52-week change133.33P/E (Trailing)‪3.25%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- PARFSXParker-Hannifin Corporation109.81BMarket Cap+26.04%52-week change35.40P/E (Trailing)‪16.96%‬Profit Margin
- MRKFSXMerck KGaA60.08BMarket Cap+13.03%52-week change25.79P/E (Trailing)‪11.21%‬Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR58.69BMarket Cap+14.60%52-week change24.77P/E (Trailing)‪11.21%‬Profit Margin
- PY3FSXGalderma Group AG39.87BMarket Cap-1.16%52-week change54.63P/E (Trailing)‪14.57%‬Profit Margin
- 0BOFSXJiangsu Hengrui Pharmaceuticals Co., Ltd.37.83BMarket Cap-75.44%52-week change37.67P/E (Trailing)‪24.93%‬Profit Margin
Profile Summary - H7T1 - HUTCHMED (China) Limited ADR
About
Hutchmed (China) Limited American Depositary Shares represent shares in HUTCHMED (China) Limited, an innovative, commercial-stage biopharmaceutical company. It specializes in the discovery, global development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases. The…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
